CCL4 and Hepatic fibrosis: More importantly, inhibiting miR-142-5p and increasing miR-130a-3p expression with LNA-modified oligonucleotides alleviated both CCL4-induced liver fibrosis and bleomycin-induced lung fibrosis, highlighting the therapeutic importance of these miRNAs.